Barium titanate (BaTiO₃), as an emerging inorganic piezoelectric material with excellent piezoelectric catalytic effects, has showing advantages in tumor therapy. To achieve ultrasound-regulated tumor treatment using BaTiO₃, researchers have developed strategies including utilizing BaTiO₃ combined with ultrasound for tumor therapy, enhancing reactive oxygen species (ROS) generation through chemical modification of BaTiO₃, and employing combined therapy with other treatment methods. These strategies provide new insights and approaches for non-invasive and precision treatment of tumors. In this review, we first explain the principle of piezoelectric effect based on BaTiO₃. Subsequently, we introduce the application of BaTiO₃ as a piezoelectric material in tumor therapy and its combined therapy with other treatment modalities in tumor treatment. Finally, we summarize the current status and limitations of BaTiO₃ in ultrasound‐triggered piezoelectric therapy for tumors and propose future prospects.

Known for being highly sensitive and noninvasive, ultrasound imaging using microbubble contrast agents is widely used in the clinic. To use ultrasound to image tissue beyond the vasculature, researchers have developed strategies that include nanobubbles, ultrasound contrast agents generated in situ, and gene expression of ultrasound contrast agents in situ. All of these strategies offer the capability of targeting tumor cells, intratumoral imaging tumor cells and require just a small incision or no incision. In this review, we will first describe the application of nanobubbles acting as ultrasound contrast agents. Then, we will briefly introduce the stimuli-responsive formulations to generate ultrasound contrast agents in situ. Finally, we will provide an overview of the use of state-of-the-art of gene expression of ultrasound contrast agents in situ to monitor cellular location and function inside living organisms.